Inovio Pharma (NASDAQ: INO) reported Q1 EPS of ($0.30), versus ($0.36) reported last year. Revenue for the quarter came in at $2.83 million, versus $1.53 million reported last year.

For earnings history and earnings-related data on Inovio Pharma (INO) click here.